• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性放化疗后挽救性食管切除术的作用。

Role of salvage esophagectomy after definitive chemoradiotherapy.

作者信息

Tachimori Yuji

机构信息

Esophageal Surgery Division, Department of Surgery, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.

出版信息

Gen Thorac Cardiovasc Surg. 2009 Feb;57(2):71-8. doi: 10.1007/s11748-008-0337-5. Epub 2009 Feb 12.

DOI:10.1007/s11748-008-0337-5
PMID:19214447
Abstract

Chemoradiotherapy has become a popular definitive therapy among many patients and oncologists for potentially resectable esophageal carcinoma. Although the complete response rates are high and short-term survival is favorable after chemoradiotherapy, persistent or recurrent locoregional disease is quite frequent. Salvage surgery is the sole curative intent treatment option for this course. As experience with definitive chemoradiotherapy grows, the number of salvage surgeries may increase. Selected articles about salvage esophagectomy after definitive chemoradiotherapy for esophageal carcinoma are reviewed. The number of salvage surgeries was significantly lower than the number of expected candidates. To identify candidates for salvage surgery, patients undergoing definitive chemoradiotherapy should be followed up carefully. Salvage esophagectomy is difficult when dissecting fibrotic masses from irradiated tissues. Patients who underwent salvage esophagectomy had increased morbidity and mortality. Pulmonary complications such as pneumonia and acute respiratory distress syndrome were common. The anastomotic leak rate was significantly increased because of the effects of the radiation administered to the tissues used as conduits. The most significant factor associated with long-term survival appeared to be complete resection. However, precise evaluation of resectability before operation was difficult. Nevertheless, increased morbidity and mortality will be acceptable in exchange for potential long-term survival after salvage esophagectomy. Such treatment should be considered for carefully selected patients at specialized centers.

摘要

对于潜在可切除的食管癌患者,放化疗已成为许多患者和肿瘤学家常用的确定性治疗方法。尽管放化疗后的完全缓解率较高且短期生存率良好,但局部区域疾病的持续或复发却相当常见。挽救性手术是针对此病程的唯一具有治愈意图的治疗选择。随着确定性放化疗经验的增加,挽救性手术的数量可能会增加。本文回顾了有关食管癌确定性放化疗后挽救性食管切除术的相关文献。挽救性手术的数量明显低于预期候选者的数量。为了确定挽救性手术的候选者,应对接受确定性放化疗的患者进行仔细随访。从受照射组织中分离纤维化肿块时,挽救性食管切除术难度较大。接受挽救性食管切除术的患者发病率和死亡率增加。肺部并发症如肺炎和急性呼吸窘迫综合征很常见。由于对用作管道的组织进行放疗的影响,吻合口漏率显著增加。与长期生存相关的最重要因素似乎是完全切除。然而,术前对可切除性进行精确评估很困难。尽管如此,为了挽救性食管切除术后潜在的长期生存,增加的发病率和死亡率是可以接受的。对于在专业中心经过精心挑选的患者,应考虑这种治疗方法。

相似文献

1
Role of salvage esophagectomy after definitive chemoradiotherapy.根治性放化疗后挽救性食管切除术的作用。
Gen Thorac Cardiovasc Surg. 2009 Feb;57(2):71-8. doi: 10.1007/s11748-008-0337-5. Epub 2009 Feb 12.
2
Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma.食管鳞状细胞癌大剂量放化疗后的挽救性食管切除术
J Thorac Cardiovasc Surg. 2009 Jan;137(1):49-54. doi: 10.1016/j.jtcvs.2008.05.016.
3
Salvage esophagectomy after failed definitive chemoradiation for esophageal adenocarcinoma.根治性放化疗失败后的食管腺癌挽救性切除术。
Ann Thorac Surg. 2012 Oct;94(4):1126-32; discussion 1132-3. doi: 10.1016/j.athoracsur.2012.05.106. Epub 2012 Aug 24.
4
Clinical significance of salvage esophagectomy for remnant or recurrent cancer following definitive chemoradiotherapy.根治性放化疗后残灶或复发食管癌挽救性切除术的临床意义。
J Gastroenterol. 2011 Nov;46(11):1284-91. doi: 10.1007/s00535-011-0448-0. Epub 2011 Aug 5.
5
Salvage esophagectomy for locoregional failure after chemoradiotherapy in patients with advanced esophageal cancer.放化疗后局部区域复发的晚期食管癌患者行挽救性食管切除术。
Ann Thorac Surg. 2012 Dec;94(6):1862-8. doi: 10.1016/j.athoracsur.2012.07.042. Epub 2012 Sep 7.
6
Factors influencing the long-term survival in patients with esophageal cancer who underwent esophagectomy after chemoradiotherapy.放化疗后食管癌切除术患者长期生存的影响因素。
World J Surg. 2010 Feb;34(2):277-84. doi: 10.1007/s00268-009-0331-9.
7
Clinical Significance of Salvage Esophagectomy for Patients with Esophageal Cancer and Factors of Influencing Long-term Survival.挽救性食管癌切除术对食管癌患者的临床意义及影响长期生存的因素
Anticancer Res. 2017 Sep;37(9):5045-5051. doi: 10.21873/anticanres.11920.
8
Systematic review and meta-analysis on the significance of salvage esophagectomy for persistent or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy.关于挽救性食管切除术对确定性放化疗后持续性或复发性食管鳞状细胞癌的意义的系统评价和荟萃分析。
Dis Esophagus. 2016 Oct;29(7):734-739. doi: 10.1111/dote.12399. Epub 2015 Aug 28.
9
Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus.食管鳞状细胞癌放化疗失败后的挽救性手术
Eur J Surg Oncol. 2009 Mar;35(3):289-94. doi: 10.1016/j.ejso.2008.02.014. Epub 2008 Apr 8.
10
Prognostic Factors of Salvage Esophagectomy for Residual or Recurrent Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy.根治性放化疗后残留或复发食管鳞状细胞癌挽救性食管切除术的预后因素
World J Surg. 2018 Sep;42(9):2887-2893. doi: 10.1007/s00268-018-4536-7.

引用本文的文献

1
Treatment Outcomes and Risk Factors for Incomplete Treatment after Definitive Chemoradiotherapy for Non-Resectable or Metastatic Esophageal Cancer.不可切除或转移性食管癌根治性放化疗后治疗结局及治疗未完成的危险因素
Cancers (Basel). 2023 Nov 15;15(22):5421. doi: 10.3390/cancers15225421.
2
Primary tracheobronchial necrosis after esophagectomy: A nationwide multicenter retrospective study in Japan.食管癌切除术后原发性气管支气管坏死:日本全国多中心回顾性研究
Ann Gastroenterol Surg. 2022 Oct 8;7(2):236-246. doi: 10.1002/ags3.12625. eCollection 2023 Mar.
3
Risk factors of esophageal fistula induced by re-radiotherapy for recurrent esophageal cancer with local primary site.

本文引用的文献

1
A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708).I期食管鳞状细胞癌同步放化疗的II期试验:日本临床肿瘤学组研究(JCOG9708)
Jpn J Clin Oncol. 2009 Oct;39(10):638-43. doi: 10.1093/jjco/hyp069. Epub 2009 Jun 23.
2
Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus.食管鳞状细胞癌放化疗失败后的挽救性手术
Eur J Surg Oncol. 2009 Mar;35(3):289-94. doi: 10.1016/j.ejso.2008.02.014. Epub 2008 Apr 8.
3
Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.
局部复发食管癌再次放疗后并发食管瘘的危险因素。
BMC Cancer. 2022 Feb 24;22(1):207. doi: 10.1186/s12885-022-09319-4.
4
Salvage esophagectomy combined with partial aortic wall resection following thoracic endovascular aortic repair.胸主动脉腔内修复术后挽救性食管切除术联合部分主动脉壁切除术
Gen Thorac Cardiovasc Surg. 2018 Dec;66(12):736-743. doi: 10.1007/s11748-018-1013-z. Epub 2018 Sep 15.
5
Neoadjuvant Chemoradiotherapy Improving Survival Outcomes for Esophageal Carcinoma: An Updated Meta-analysis.新辅助放化疗改善食管癌生存结局:一项更新的荟萃分析。
Chin Med J (Engl). 2016 Dec 20;129(24):2974-2982. doi: 10.4103/0366-6999.195464.
6
Prognostic factors for salvage endoscopic resection for esophageal squamous cell carcinoma after chemoradiotherapy or radiotherapy alone.单纯放化疗或单纯放疗后食管鳞状细胞癌挽救性内镜切除的预后因素
Endosc Int Open. 2016 Aug;4(8):E841-8. doi: 10.1055/s-0042-109609. Epub 2016 Aug 9.
7
Definitive chemoradiotherapy and salvage esophagectomy for esophageal cancer associated with multiple lung metastases: a case report.食管癌伴多发肺转移的根治性放化疗及挽救性食管切除术:一例报告
Int Surg. 2014 Sep-Oct;99(5):640-4. doi: 10.9738/INTSURG-D-13-00123.1.
8
Clinicopathological factors predicting R0 resection and long-term survival after esophagectomy in patients with T4 esophageal cancer undergoing induction chemotherapy or chemoradiotherapy.接受诱导化疗或放化疗的T4期食管癌患者行食管切除术后预测R0切除及长期生存的临床病理因素
Surg Today. 2015 Apr;45(4):479-86. doi: 10.1007/s00595-014-0980-7. Epub 2014 Jul 25.
9
Salvage lymphadenectomy for recurrent esophageal cancer after chemoradiotherapy.同步放化疗后复发性食管癌的挽救性淋巴结清扫术
Int Surg. 2014 Jul-Aug;99(4):452-7. doi: 10.9738/INTSURG-D-13-00261.1.
10
Hyperglycemia 3 days after esophageal cancer surgery is associated with an increased risk of postoperative infection.食管癌手术后3天出现高血糖与术后感染风险增加相关。
J Gastrointest Surg. 2014 Sep;18(9):1547-56. doi: 10.1007/s11605-014-2587-0. Epub 2014 Jul 4.
顺铂、氟尿嘧啶、放疗及手术三联疗法与单纯手术治疗食管癌的III期试验:癌症和白血病B组9781研究
J Clin Oncol. 2008 Mar 1;26(7):1086-92. doi: 10.1200/JCO.2007.12.9593.
4
Salvage esophagectomy following definitive chemoradiotherapy.根治性放化疗后挽救性食管切除术
Gen Thorac Cardiovasc Surg. 2007 Nov;55(11):461-4; discussion 464-5. doi: 10.1007/s11748-007-0157-z.
5
Outcomes from salvage esophagectomy post definitive chemoradiotherapy compared with resection following preoperative neoadjuvant chemoradiotherapy.与术前新辅助放化疗后切除相比,根治性放化疗后挽救性食管切除术的结果。
Dis Esophagus. 2007;20(6):471-7. doi: 10.1111/j.1442-2050.2007.00701.x.
6
Salvage esophagectomy after definitive chemoradiotherapy for esophageal cancer.
Dis Esophagus. 2007;20(4):301-4. doi: 10.1111/j.1442-2050.2007.00677.x.
7
American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects.美国临床肿瘤学会关于成年癌症幸存者持续护理的临床证据综述:心脏和肺部迟发效应
J Clin Oncol. 2007 Sep 1;25(25):3991-4008. doi: 10.1200/JCO.2007.10.9777. Epub 2007 Jun 18.
8
Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy.(18)F-氟脱氧葡萄糖正电子发射断层扫描的完全代谢反应在食管癌术前放化疗后预测病理反应和生存中的价值。
Eur J Cancer. 2007 Jun;43(9):1385-91. doi: 10.1016/j.ejca.2007.04.001. Epub 2007 May 23.
9
Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.与单纯放化疗相比,放化疗后手术治疗食管鳞癌:FFCD 9102研究
J Clin Oncol. 2007 Apr 1;25(10):1160-8. doi: 10.1200/JCO.2005.04.7118.
10
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.新辅助放化疗或化疗对食管癌患者的生存获益:一项荟萃分析。
Lancet Oncol. 2007 Mar;8(3):226-34. doi: 10.1016/S1470-2045(07)70039-6.